Seres Therapeutics (MCRB) Times Interest Earned (2014 - 2026)
Seres Therapeutics (MCRB) posted Times Interest Earned of -$4.2 for Q1 2026, down 2202.0% sequentially from -$0.18 in Q3 2025, and up 24.84% YoY from -$3.36 in Q1 2025.
Seres Therapeutics (MCRB) Times Interest Earned (2014 - 2026) Analysis & Trends
Seres Therapeutics has reported Times Interest Earned for 13 years, with the latest figure at -$4.2 in Q1 2026.
- Quarterly Times Interest Earned rose 24.84% year-over-year to -$4.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.37 (down 3.81% YoY) and the FY2025 annual result came in at -$0.3, up 22.84% from the prior year.
- Times Interest Earned fell to -$4.2 in Q1 2026 per MCRB's latest filing, from -$0.18 in the prior quarter.
- Over five years, Times Interest Earned peaked at $7.25 in Q2 2023 and troughed at -$26.38 in Q1 2022.
- A 5-year average of -$5.55 and a median of -$4.33 in 2024 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 9882.99% in 2023, down 281364.59% in 2023.
- Over 5 years, Times Interest Earned stood at -$0.03 in 2022, then tumbled by 12637.36% to -$3.67 in 2023, then slipped by 21.29% to -$4.46 in 2024, then surged by 95.91% to -$0.18 in 2025, then slumped by 2202.0% to -$4.2 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$4.2, -$0.18, and -$0.19 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Seres Therapeutics | 43.87 Mn | 43.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.28 |
| Mar 31, 2026 | -4.20 |
| Sep 30, 2025 | -0.18 |
| Jun 30, 2025 | -0.19 |
| Mar 31, 2025 | -5.58 |
| Dec 31, 2024 | -4.46 |
| Sep 30, 2024 | -5.44 |
| Jun 30, 2024 | -5.39 |
| Mar 31, 2024 | -9.58 |
| Dec 31, 2023 | -3.67 |
| Sep 30, 2023 | -10.14 |
| Jun 30, 2023 | 7.25 |
| Mar 31, 2023 | -20.68 |
| Dec 31, 2022 | -0.03 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | -0.07 |
| Mar 31, 2022 | -26.38 |
| Dec 31, 2021 | -66.98 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | -0.34 |